ATE90869T1 - Im wesentlichen aus triglyceriden gesaettigter fettsaeuren bestehende, mit einem wirkstoff beladene mikrogranulate und ihre aeusserliche therapeutische anwendung. - Google Patents

Im wesentlichen aus triglyceriden gesaettigter fettsaeuren bestehende, mit einem wirkstoff beladene mikrogranulate und ihre aeusserliche therapeutische anwendung.

Info

Publication number
ATE90869T1
ATE90869T1 AT89403675T AT89403675T ATE90869T1 AT E90869 T1 ATE90869 T1 AT E90869T1 AT 89403675 T AT89403675 T AT 89403675T AT 89403675 T AT89403675 T AT 89403675T AT E90869 T1 ATE90869 T1 AT E90869T1
Authority
AT
Austria
Prior art keywords
loaded
fatty acid
microgranules
saturated fatty
active substance
Prior art date
Application number
AT89403675T
Other languages
English (en)
Inventor
Jean-Claude Jamoulle
Josiane Les Vergers De V Allec
Alain Brzokewicz
Braham Shroot
Original Assignee
Cird Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird Galderma filed Critical Cird Galderma
Application granted granted Critical
Publication of ATE90869T1 publication Critical patent/ATE90869T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/671Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
AT89403675T 1988-12-29 1989-12-28 Im wesentlichen aus triglyceriden gesaettigter fettsaeuren bestehende, mit einem wirkstoff beladene mikrogranulate und ihre aeusserliche therapeutische anwendung. ATE90869T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU87416A LU87416A1 (fr) 1988-12-29 1988-12-29 Microgranules charges en une substance active,constitues essentiellement d'un triglyceride d'acides gras satures et leur utilisation par voie topique dans le domaine therapeutique
EP89403675A EP0376852B1 (de) 1988-12-29 1989-12-28 Im wesentlichen aus Triglyceriden gesättigter Fettsäuren bestehende, mit einem Wirkstoff beladene Mikrogranulate und ihre äusserliche therapeutische Anwendung

Publications (1)

Publication Number Publication Date
ATE90869T1 true ATE90869T1 (de) 1993-07-15

Family

ID=19731128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89403675T ATE90869T1 (de) 1988-12-29 1989-12-28 Im wesentlichen aus triglyceriden gesaettigter fettsaeuren bestehende, mit einem wirkstoff beladene mikrogranulate und ihre aeusserliche therapeutische anwendung.

Country Status (16)

Country Link
EP (1) EP0376852B1 (de)
JP (1) JP2731008B2 (de)
KR (1) KR900009058A (de)
AT (1) ATE90869T1 (de)
AU (1) AU617570B2 (de)
CA (1) CA2006834A1 (de)
DE (2) DE376852T1 (de)
DK (1) DK669789A (de)
ES (1) ES2034951T3 (de)
FI (1) FI896321A0 (de)
GR (1) GR910300044T1 (de)
LU (1) LU87416A1 (de)
NO (1) NO895307L (de)
NZ (1) NZ231982A (de)
PT (1) PT92747A (de)
ZA (1) ZA899961B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649608B1 (fr) * 1989-07-12 1991-10-11 Oreal Composition cosmetique sous forme d'un gel aqueux contenant en suspension des spheroides d'une substance lipidique solide non hydrophile
DE4336407A1 (de) * 1993-10-21 1995-04-27 Rotring Int Gmbh Wasserfeste Kosmetik
FR2721210B1 (fr) * 1994-06-17 1996-08-02 Oreal Composition de nettoyage contenant des grains lipidiques.
US5540920A (en) * 1994-11-22 1996-07-30 Olin Corporation Synergistic biocide composition containing pyrithione plus an additive
US5679648A (en) * 1994-11-30 1997-10-21 The University Hospital Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
FR2737668B1 (fr) * 1995-08-08 1997-10-31 Rocher Yves Biolog Vegetale Billes a base de substances lipophiles, leur procede de fabrication et leurs applications
JPH09268118A (ja) * 1996-04-01 1997-10-14 Kao Corp 肌色改善美容剤
DE19738247C2 (de) * 1997-09-02 2000-02-17 Goldwell Gmbh Haarpflegemittel
DE19952790A1 (de) * 1999-11-03 2001-05-17 Cognis Deutschland Gmbh Verfahren zur Herstellung von Fettstoffgranulaten
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
AU2003223005A1 (en) 2002-05-06 2003-11-17 Vectura Limited Application device for topical administration of pharmaceutical agents
US8980235B2 (en) * 2003-09-30 2015-03-17 Arch Chemicals, Inc. Coated metal pyrithione particles for treatment of microorganisms
US9861605B2 (en) 2011-10-24 2018-01-09 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
FR3075635B1 (fr) * 2017-12-22 2019-12-06 Lvmh Recherche Procede de preparation de spheroides anhydres par cryogenie
KR102446371B1 (ko) * 2019-06-11 2022-09-22 대봉엘에스 주식회사 유지 조성물 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
DE2309202A1 (de) * 1973-02-21 1974-08-29 Schering Ag Arzneiformen mit mikroverkapseltem arzneimittelwirkstoff
DE2725924C3 (de) * 1977-06-08 1980-11-06 Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau Verfahren zur Herstellung kugelförmiger Teilchen aus niedrigschmelzenden organischen Substanzen

Also Published As

Publication number Publication date
GR910300044T1 (en) 1991-11-15
JP2731008B2 (ja) 1998-03-25
FI896321A0 (fi) 1989-12-28
KR900009058A (ko) 1990-07-02
DE376852T1 (de) 1991-07-04
PT92747A (pt) 1990-06-29
AU4730689A (en) 1990-07-05
NZ231982A (en) 1991-03-26
EP0376852A1 (de) 1990-07-04
LU87416A1 (fr) 1990-07-10
DE68907335T2 (de) 1994-01-13
NO895307D0 (no) 1989-12-28
EP0376852B1 (de) 1993-06-23
ZA899961B (en) 1990-10-31
JPH02300116A (ja) 1990-12-12
DK669789D0 (da) 1989-12-28
NO895307L (no) 1990-07-02
ES2034951T3 (es) 1994-10-16
AU617570B2 (en) 1991-11-28
ES2034951T1 (es) 1993-04-16
DK669789A (da) 1990-06-30
CA2006834A1 (fr) 1990-06-29
DE68907335D1 (de) 1993-07-29

Similar Documents

Publication Publication Date Title
ATE90869T1 (de) Im wesentlichen aus triglyceriden gesaettigter fettsaeuren bestehende, mit einem wirkstoff beladene mikrogranulate und ihre aeusserliche therapeutische anwendung.
ATE63464T1 (de) Spruehgetrocknetes acetaminophen.
HUT50624A (en) Process for producing pharmaceuical compositions with controlled release of active ingredient
DE68903442T2 (de) Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
DK415689A (da) Farmaceutiske midler
DE68906477T2 (de) Zubereitungen mit verzoegerter freisetzung sowie deren herstellung.
ATE66139T1 (de) Kosmetische zusammensetzung.
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
EP0302481A3 (de) Verwendung von freien Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von Diabetes mellitus
OA05647A (fr) Nouveaux esters d'acides cyclopropanecarboxyliques, leur préparation et leur application à la lutte contre les parasites.
IL61418A (en) Fluorine-substituted benzyl esters of 2,2,3,3-tetramethyl cyclopropane-1-carboxylic acid,their preparation and their use as pesticides
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
IT8021037A0 (it) Composizioni insetticide che esteri sostituiti dell'acido contengono i medesimi come ciclopropancarbossilico e ingrediente attivo.
JPS5515472A (en) 22cyclopropyllpyrimidinee44yllthionophosphoric acid esters*their manufacture and their use as insecticide and miticide
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
IL66742A (en) Derivatives of 2,2-dimethyl-3-haloalkenyl-cyclopropane carboxylic acid esters with fluorinated-3-trifluoromethoxy benzyl alcohols and 5-(2-fluoro-1,3-benzodioxole)methanols,their preparation and their use as pesticides
SE8405611D0 (sv) Process for stabilization of bacampicillin hydrochloride
FR2460111B2 (fr) Composition a base d'un melange aqueux de n-methyl-2-pyrrolidone et d'acide 2-halogenethylphosphonique et son application au traitement de plantes
EG14317A (en) Herbicidally active n-(2-propynyl)-carbanilic acid (3-aliphatic hydrocarbon-oxy-or-thio carbonylaminophenyl)esters and their manufacture and use
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
BE860687A (fr) Nouveaux esters d'acides carboxyliques aliphatiques, leur preparation et leur application a la lutte contre les parasites
NO165396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-5-karboksylsyre-estere.
IT8821430A0 (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
TR19696A (tr) Herbist olarak aktif 2-(dimetil-karbamoylimino)-1,3,4-tiyadiya-zolin-3 karboksilik asit esterleri,bunlarin imali usulue ve kullanilmalari
OA06590A (fr) Esters d'acides cyclopropane carboxyliques, leur procédé de préparation et les compositions pesticides les renfermant.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties